With a blockbuster portfolio and a pipeline brimming with potential, Axsome Therapeutics is proving its five-year market surge may be only the beginning. Analysts point to label expansions and untapped markets as key drivers for the next phase of growth.
The Danish pharmaceutical giant forecasts a significant drop in revenue for the year, citing fierce competition for its weight-loss drugs and U.S. government pricing initiatives. The projected decline steeper than analyst expectations triggered a sharp sell-off in its U.S.-listed shares.
Spire Inc. (SR) reported robust first-quarter earnings, crediting its natural gas utilities' performance during a historic winter storm and reaffirming its growth targets as it advances a major acquisition and portfolio simplification.
New Phase 3 data for Novo Nordisk's CagriSema shows superior blood sugar control and weight loss compared to its own semaglutide in type 2 diabetes patients. However, analysts note the therapy enters a market where Eli Lilly's tirzepatide has already set a high bar for dual-benefit treatments.
Siemens Energy is making a major investment in its North Carolina manufacturing footprint, committing $421 million to expand operations and create approximately 500 new jobs focused on building critical energy infrastructure.
The autonomous vehicle leader, backed by a massive new capital infusion, reports its ride volume tripled to 15 million trips in 2025 as it sets sights on international growth.
In its first earnings call under new CEO Ron Lewis and CFO Daniel Rabbitt, Ball Corporation reported strong 2025 results and outlined a strategic growth runway fueled by recent acquisitions in Europe and expanded manufacturing capacity in the United States.
Alphabet's self-driving unit Waymo has secured a massive $16 billion investment, led by Dragoneer, DST Global, and Sequoia, fueling an aggressive international expansion plan set to launch in over 20 new cities by 2026.
Shares of the institutional crypto firm Galaxy Digital plunged after it reported a $482 million loss for the fourth quarter, driven by a sharp decline in the value of its digital asset holdings and investment portfolio.
NXP Semiconductors shares tumbled sharply Thursday morning, as the chipmaker's Q4 earnings report revealed underlying pressures on inventory levels and margins that overshadowed its headline revenue and profit beats.
PJT Partners stock fell sharply after reporting fourth-quarter earnings that topped estimates but revenue that fell short of Wall Street's expectations, highlighting investor concerns over the firm's growth outlook.
Relocating during retirement offers new beginnings but also introduces complex financial and healthcare planning challenges. Here’s what future retirees need to know about managing Social Security and Medicare benefits ahead of a move.
Archer-Daniels-Midland Company reported mixed Q4 2025 results, with strong cost management and cash flow offsetting market challenges. The agribusiness giant outlined a cautiously optimistic 2026 outlook, pinning hopes on policy clarity for biofuels and a continued recovery in its Nutrition segment.
J&J Snack Foods Corp. saw its stock plunge more than 14% Thursday morning after reporting quarterly results that fell short of analyst expectations on both top and bottom lines, extending a challenging year for the snack maker.
BellRing Brands stock fell sharply after its Q4 report highlighted severe margin compression and a trimmed revenue forecast, shifting investor focus away from top- and bottom-line beats.
Shares of dialysis giant DaVita Inc. soared more than 25% following a fourth-quarter earnings beat and a robust profit forecast for 2026 that exceeded analyst expectations, signaling renewed confidence in the company's growth trajectory.
Shares of aerospace and defense manufacturer Woodward, Inc. (WWD) surged over 16% Thursday, hitting a new 52-week high after the company reported quarterly results that crushed analyst expectations, driven by strength in its core markets.
Pfizer Inc. reported stronger-than-expected Q4 and full-year 2025 results, returning $9.8 billion to shareholders. The pharmaceutical giant is navigating a pivotal transition, leveraging recent acquisitions and a promising obesity drug pipeline to offset upcoming patent expirations and drive growth beyond 2028.
The premium outdoor brand appoints Tommy Hilfiger alum Avery Baker to a newly created role, alongside a new EMEA managing director from Celine, signaling an aggressive strategy to expand its global footprint and connect with wider audiences.
Jackson T. Keller, a 19-year-old Fort Lewis College student, faces serious charges including criminal solicitation for first-degree murder after allegedly plotting to pay for a fellow student's killing.
